Abstract: Objects of the present invention are to provide a method for directly obtaining pluripotent stem cells which do not have tumorigenic property from body tissue and the thus obtained pluripotent stem cells. The present invention relates to SSEA-3 (+) pluripotent stem cells that can be isolated from body tissue.

Abstract: The purpose of the present invention is to identify a migratory factor that guides pluripotent stem cells (Muse cells) useful in new medical applications to damage, and to provide a pharmaceutical composition that includes the migratory factor for promoting tissue regeneration in regenerative medicine that makes use of Muse cells. In the present invention, a receptor that is specifically expressed in Muse cells rather than non-Muse cells was identified, and it was confirmed that a ligand for this receptor can function as a migratory factor. In the present invention, sphingosine-1-phosphate (S1P) was identified as a migratory factor, and thus, the present invention pertains to a pharmaceutical composition for guiding pluripotent stem cells to damage, the composition including S1P as an active ingredient.

Abstract: An aqueous ink for ink jet including a resin particle. The resin particle includes a first layer and a second layer in this order from the inside to the outside thereof. The first layer is composed of a first resin, wherein the proportion of a unit derived from an aromatic-group-containing ethylenically unsaturated monomer in the first resin is 10% by mass or less. The second layer has a tetrahydrofuran-insoluble fraction of 10% by mass or more and is composed of a second resin having a unit derived from an aromatic-group-containing ethylenically unsaturated monomer and a unit derived from an ionic-group-containing ethylenically unsaturated monomer, wherein the proportion of the unit derived from the ionic-group-containing ethylenically unsaturated monomer in the second resin is 3% by mass or more to 70% by mass or less.

Abstract: A box includes a front receiving panel, a bottom surface panel, a rear surface panel, a top surface panel, and a front surface panel that are integrally connected one to another. Each pair of bottom side panels, rear side panels, top side panels, and front side panels are integrally connected to the respective sides of each of the bottom, rear, top, and front surface panels. The front receiving panel, the bottom and rear surface panels, and the bottom and rear side panels constitute a tray portion of the box, with the remaining panels constituting a lid portion of the box. A cut line for separating the lid portion from the tray portion is formed to pass through one or both of the rear surface panel and the top surface panel.

Abstract: The purpose of the present invention is to identify a migratory factor that guides pluripotent stem cells (Muse cells) useful in new medical applications to damage, and to provide a pharmaceutical composition that includes the migratory factor for promoting tissue regeneration in regenerative medicine that makes use of Muse cells. In the present invention, a receptor that is specifically expressed in Muse cells rather than non-Muse cells was identified, and it was confirmed that a ligand for this receptor can function as a migratory factor. In the present invention, sphingosine-1-phosphate (S1P) was identified as a migratory factor, and thus, the present invention pertains to a pharmaceutical composition for guiding pluripotent stem cells to damage, the composition including S1P as an active ingredient.

Abstract: An object of the present invention is to provide a novel medical application to regenerative medicine that uses pluripotent stem cells (Muse cells). The present invention provides a cell preparation for treating cerebral infarction and sequelae associated therewith that contains SSEA-3-positive pluripotent stem cells isolated from mesenchymal tissue in the body or cultured mesenchymal cells. The cell preparation of the present invention is based on a brain tissue regeneration mechanism by which Muse cells differentiate into nerve cells and the like in damaged brain tissue by administering Muse cells into cerebral parenchyma.

Abstract: An object of the present invention is to provide a novel medical application to regenerative medicine that uses pluripotent stem cells (Muse cells). The present invention provides a cell preparation for treating chronic kidney disease that contains SSEA-3-positive pluripotent stem cells isolated from mesenchymal tissue in the body or cultured mesenchymal cells. The cell preparation of the present invention is based on a renal tissue regeneration mechanism by which Muse cells are made to selectively accumulate at a site of kidney disease and differentiate into cells that compose the kidney by administering Muse cells intravenously to a subject having the aforementioned disease.

Abstract: The purpose of the present invention is to identify a migratory factor that guides pluripotent stem cells (Muse cells) useful in new medical applications to damage, and to provide a pharmaceutical composition that includes the migratory factor for promoting tissue regeneration in regenerative medicine that makes use of Muse cells. In the present invention, a receptor that is specifically expressed in Muse cells rather than non-Muse cells was identified, and it was confirmed that a ligand for this receptor can function as a migratory factor. In the present invention, sphingosine-1-phosphate (S1P) was identified as a migratory factor, and thus, the present invention pertains to a pharmaceutical composition for guiding pluripotent stem cells to damage, the composition including S1P as an active ingredient.

Abstract: A chip stack (11) is configured by stacking at least first, second, and third semiconductor chips (10a, 10b, 10c). The first semiconductor chip (10a) has bump electrodes formed only on one side thereof. The second semiconductor chip (10b) has bump electrodes formed on both sides thereof and they are electrically connected each other. The second semiconductor chip (10b) is stacked on and electrically connected to the first semiconductor chip (10a) through a first solder layer. The third semiconductor chip (10c) has bump electrodes formed on both sides thereof and they are electrically connected each other. Second and third solder layers are formed on the bump electrodes on the both sides of the third semiconductor chip. The third semiconductor chip (10c) is stacked on and electrically connected to the second semiconductor chip (10b) through the third solder layer.

Abstract: An object of the present invention is to provide a novel medical application for use in regenerative medicine that uses pluripotent stem cells (Muse cells). The present invention provides a cell preparation for treating myocardial infarction, and particularly serious massive myocardial infarction and heart failure associated therewith, that contains pluripotent stem cells positive for SSEA-3 isolated from biological mesenchymal tissue or cultured mesenchymal cells. The cell preparation of the present invention is based on a cardiac tissue regeneration mechanism by which Muse cells are made to selectively accumulate in damaged myocardial tissue and differentiate into cardiac muscle in that tissue as a result of intravenous administration of Muse cells to a subject presenting with the aforementioned disorders.

Abstract: The present invention provides a hydrodesulfurization catalyst that exhibits a high desulfurization activity when used in hydrotreatment of hydrocarbon oil, in particular straight-run gas oil. The catalyst includes at least one type of metal component selected from Groups VIA and VIII in the periodic table, supported on a silica-titania-alumina support where the total of the diffraction peak area indicating the crystal structure of anatase titania (101) planes and the diffraction peak area indicating the crystal structure of rutile titania (110) planes is ¼ or less of the diffraction peak area indicating the aluminum crystal structure ascribed to ?-alumina (400) planes, as measured by X-ray diffraction analysis. The catalyst has (a) a specific surface area (SA) of 150 m2/g or greater, (b) a total pore volume (PVo) of 0.

Abstract: A hydrodesulfurization catalyst is produced by pre-sulfurizing a hydrodesulfurization catalyst Y including a support containing silica, alumina and titania and at least one metal component supported thereon and selected from VIA and VIII groups of the periodic table (comprising at least Mo), in which the total area of the diffraction peak area indicating the crystal structure of anatase titania (101) planes and the diffraction peak area indicating the crystal structure of rutile titania (110) planes in the support, measured by X-ray diffraction analysis being ¼ or less of the alumina diffraction peak area assigned to ?-alumina (400) planes. The molybdenum is formed into molybdenum disulfide crystal disposed in layers on the support by the pre-sulfurization, and having an average length of longer than 3.5 nm and 7 nm or shorter in the plane direction and an average number of laminated layers of more than 1.0 and 1.9 or fewer.

Abstract: A semiconductor device includes a chip stacked structure. The chip stacked structure may include, but is not limited to, first and second semiconductor chips. The first semiconductor chip has a first thickness. The second semiconductor chip has a second thickness that is thinner than the first thickness.

Abstract: A hydrotreating catalyst that exhibits excellent levels of both desulfurization activity and denitrification activity. The hydrotreating catalyst is prepared by supporting molybdenum, cobalt and nickel on a carrier comprising aluminum, silicon, phosphorus and boron, and then performing a presulfiding treatment, and has an average stacking number for molybdenum sulfide slab that is greater than 1.0 but not more than 1.9. Also, a process for producing a hydrotreating catalyst that enables a hydrotreating catalyst having excellent levels of both desulfurization activity and denitrification activity to be produced with comparative ease. The process includes a first step of mixing an acidic aluminum salt aqueous solution and a basic aluminum salt aqueous solution in the presence of phosphate ions and silicate ions to achieve a pH of 6.5 to 9.

Abstract: A semiconductor device includes a first wiring board, a second semiconductor chip, and a second seal. The first wiring board includes a first substrate, a first semiconductor chip, and a first seal. The first semiconductor chip is disposed on the first substrate. The first seal is disposed on the first substrate. The first seal surrounds the first semiconductor chip. The first seal has the same thickness as the first semiconductor chip. The second semiconductor chip is stacked over the first semiconductor chip. The first semiconductor chip is between the second semiconductor chip and the first substrate. The second semiconductor chip is greater in size in plan view than the first semiconductor chip. The second seal seals at least a first gap between the first semiconductor chip and the second semiconductor chip.

Abstract: A semiconductor device includes a first wiring board, a second semiconductor chip, and a second seal. The first wiring board includes a first substrate, a first semiconductor chip, and a first seal. The first semiconductor chip is disposed on the first substrate. The first seal is disposed on the first substrate. The first seal surrounds the first semiconductor chip. The first seal has the same thickness as the first semiconductor chip. The second semiconductor chip is stacked over the first semiconductor chip. The first semiconductor chip is between the second semiconductor chip and the first substrate. The second semiconductor chip is greater in size in plan view than the first semiconductor chip. The second seal seals at least a first gap between the first semiconductor chip and the second semiconductor chip.

Abstract: In an organic electroluminescence display device which includes: a display region DR in which a plurality of pixels are arranged; and a power source part CC which is arranged outside the display region, each of the plurality of pixels includes: a lower electrode An; a light emitting layer stacked above the lower electrode; and an upper electrode which includes a thin silver film AG and is formed by a layer shared in common by other pixels above the light emitting layer, the upper electrode extends to the power source part for electrically connection, the thin silver film has a portion arranged between the display region and the power source part, and a background layer containing an electron pair donor is arranged as a background of at least a portion of the thin silver film between the display region and the power source part.

Abstract: A semiconductor device includes a first wiring hoard, a second semiconductor chip, and a second seal. The first wiring board includes a first substrate, a first semiconductor chip, and a first seal. The first semiconductor chip is disposed on the first substrate. The first seal is disposed on the first substrate. The first seal surrounds the first semiconductor chip. The first seal has the same thickness as the first semiconductor chip. The second semiconductor chip is stacked over the first semiconductor chip. The first semiconductor chip is between the second semiconductor chip and the first substrate. The second semiconductor chip is greater in size in plan view than the first semiconductor chip. The second seal seals at least a first gap between the first semiconductor chip and the second semiconductor chip.

Abstract: A hydrodesulfurization catalyst is produced by pre-sulfurizing a hydrodesulfurization catalyst Y including a support containing silica, alumina and titania and at least one metal component supported thereon and selected from VIA and VIII groups of the periodic table (comprising at least Mo), in which the total area of the diffraction peak area indicating the crystal structure of anatase titania (101) planes and the diffraction peak area indicating the crystal structure of rutile titania (110) planes in the support, measured by X-ray diffraction analysis being ¼ or less of the alumina diffraction peak area assigned to ?-alumina (400) planes. The molybdenum is formed into molybdenum disulfide crystal disposed in layers on the support by the pre-sulfurization, and having an average length of longer than 3.5 nm and 7 nm or shorter in the plane direction and an average number of laminated layers of more than 1.0 and 1.9 or fewer.

Abstract: A semiconductor device includes a chip stacked body where a plurality of semiconductor chips are stacked, and penetration electrodes respectively formed in the semiconductor chips are electrically interconnected in stacking order of the semiconductor chips, a first support member that is disposed to face a first semiconductor chip formed in one end of the chip stacked body, and including electrodes electrically connected to the penetration electrodes of the first semiconductor chip, and a wiring board that is disposed to face a second semiconductor chip formed in an end opposed to the one end of the chip stacked body, and including external electrodes on a surface opposed to a surface facing the second semiconductor chip that is to be electrically connected to the penetration electrodes of the second semiconductor chip.